Search

Search Constraints

You searched for: Author/Creator Foreman, Nicholas K

Search Results

11. IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908. (3rd June 2022)

13. MBRS-22. EZH2 OVEREXPRESSION INCREASES THE ONCOGENIC CHARACTER OF CEREBELLAR PROGENITORS AND ISOGRAFTS IN MICE RESULT IN TUMORS RESEMBLING GROUP 3 MEDULLOBLASTOMA. Issue 2 (22nd June 2018)

14. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma. Issue 8 (2nd March 2018)

15. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Issue 2 (2nd June 2021)

16. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas. Issue 4 (22nd March 2021)

18. PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem. Issue 2 (28th November 2022)

19. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Issue 8 (August 2022)

20. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma. Issue 4 (10th October 2022)